Last base update: 2018-08-01
Abasaglar | sol. to shock | 100 IU / ml 100 IU / ml Eli Lilly ( Insulin glargine ) | ||
The retail price, the price without refund | PLN 357.72 | |
Name of the indication | Type of refund | Patient's payment |
Type I diabetes in adults, adolescents and children from 6 years of age | medicine for 30% of the price | PLN 107.32 |
Type 2 diabetes mellitus in patients treated with NPH insulin for at least 6 months and with HbA1c ≥8% and type 2 diabetes in patients treated with NPH insulin for at least 6 months and with documented recurrent episodes of severe or nocturnal hypoglycaemia and type 1 diabetes in children from the age of 2 up to 6 years and diabetes of known cause (as defined by the WHO) | medicine for 30% of the price | PLN 107.32 |
Lantus® | sol. to shock | 100 units / ml | 100 units / ml | Sanofi-Aventis Deutschland ( Insulin glargine ) | ||
The retail price, the price without refund | PLN 198.15 | |
Name of the indication | Type of refund | Patient's payment |
Type I diabetes in adults, adolescents and children from 6 years of age | medicine for 30% of the price | 72.95 PLN |
Type 2 diabetes mellitus in patients treated with NPH insulin for at least 6 months and with HbA1c ≥8% and type 2 diabetes in patients treated with NPH insulin for at least 6 months and with documented recurrent episodes of severe or nocturnal hypoglycaemia and type 1 diabetes in children from the age of 2 up to 6 years and diabetes of known cause (as defined by the WHO) | medicine for 30% of the price | 72.95 PLN |
Lantus® | sol. to shock | 100 units / ml | 100 units / ml | Sanofi-Aventis Deutschland ( Insulin glargine ) | ||
The retail price, the price without refund | PLN 198.15 | |
Name of the indication | Type of refund | Patient's payment |
Type I diabetes in adults, adolescents and children from 6 years of age | medicine for 30% of the price | 72.95 PLN |
Type 2 diabetes mellitus in patients treated with NPH insulin for at least 6 months and with HbA1c ≥8% and type 2 diabetes in patients treated with NPH insulin for at least 6 months and with documented recurrent episodes of severe or nocturnal hypoglycaemia and type 1 diabetes in children from the age of 2 up to 6 years and diabetes of known cause (as defined by the WHO) | medicine for 30% of the price | 72.95 PLN |